Erm no but hang on. There are people here who claim that this stock will uplist to NASDAQ and to do that, any parabolic price increases HAVE to be sustainable. Min compliance post uplist is $1/share and I understand price needs to be $4 to even get the initial listing. How on earth could a P&D stock ever hope to reach such dizzy heights and remain there. What usually happens under such circumstances is the stock gets diluted to hell, they RS at a ratio that would put the pps well above compliance levels, in order to allow for the inevitable pull back on uplist short selling activity. So say they need to reach $4, they'll RS to at least 50% above that and open at $6 allowing for the 30% drop and still remain compliant.
Incidentally, 0.07 to $1 is a roughly 1,400% increase and to $4 would be an approx 5,700%.
Common sense tells anyone this is a ridiculous notion. Which share ever did that before especially, when the world and his dog already had a heads up and the float is so huge?
Isn't it the more likely scenario we will see mass dilution of the OS to give the company the lion's share of the OS, followed by a RS to get it to parity on uplisting compliance prices, i.e. a typical OTC shares jiggery pokery play.
If I am so far out of kilter here and being a buzz kill, someone (preferably one of the people doing all the buzzing), tell me what I am missing because this stock simply does not go from 7 cents to $4 or even $1 on fluf alone and then if so, there's no uplisting as price will jump off the cliff again soon after.
I've read the due dil and I'd love to know where this aspect of the pps exponential growth is covered with reasoned plausible arguments and more importantly, factual information.
Market Data 
Markets 
AI
